Calamos Advisors LLC Rx Sight, Inc. Transaction History
Calamos Advisors LLC
- $14.5 Billion
- Q1 2024
A detailed history of Calamos Advisors LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 86,921 shares of RXST stock, worth $5.23 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
86,921
Previous 126,539
31.31%
Holding current value
$5.23 Million
Previous $5.1 Million
12.13%
% of portfolio
0.03%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding RXST
# of Institutions
198Shares Held
25.6MCall Options Held
67KPut Options Held
2K-
Black Rock Inc. New York, NY2.11MShares$127 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.9MShares$114 Million0.15% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ1.77MShares$107 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.52MShares$91.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.13MShares$67.7 Million0.0% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.66B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...